Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia

Published:2010-05-16 Issue:6 Volume:42 Page:530-535
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Kleppe Maria,Lahortiga Idoya,El Chaar Tiama,De Keersmaecker Kim,Mentens Nicole,Graux Carlos,Van Roosbroeck Katrien,Ferrando Adolfo A,Langerak Anton W,Meijerink Jules P P,Sigaux François,Haferlach Torsten,Wlodarska Iwona,Vandenberghe Peter,Soulier Jean,Cools Jan

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.587.pdf

Reference31 articles.

1. Doody, K.M., Bourdeau, A. & Tremblay, M.L. T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunol. Rev. 228, 325–341 (2009).

2. van Vliet, C. et al. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat. Immunol. 6, 253–260 (2005).

3. Shields, B.J., Hauser, C., Bukczynska, P.E., Court, N.W. & Tiganis, T. DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. Cancer Cell 14, 166–179 (2008).

4. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).

5. Todd, J.A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857–864 (2007).

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of protein phosphorylation by PTPN2 and its small-molecule inhibitors/degraders as a potential disease treatment strategy;European Journal of Medicinal Chemistry;2024-11

2. PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL;npj Precision Oncology;2024-07-20

3. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13

4. Targeting protein tyrosine phosphatase non-receptor type 2 with a novel inhibitor for AML therapy;2024-05-10

5. Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies;Cells;2024-01-25